Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Additive glucose-lowering effect of a dipeptidyl peptidase-4 (DPP4) inhibitor and an alpha-glucosidase inhibitor (AGI) might be beneficial in patients with T2DM.
Read More »Greater HbA1c Reduction with DPP4 Inhibitor, AGI Combination
Safety and Efficacy of a New Long-Acting Exenatide Formulation: BYDUREON® BCise™
Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.
Read More »Efficacy And Safety When Adding Ertugliflozin to Metformin and Sitagliptin
New SGLT-2 inhibitor can be used as add-on therapy to provide better improvement in HbA1C in patients with type 2 diabetes.
Read More »Maternal Obesity and its Association to Type 1 Diabetes in Children
Obesity, independent of diabetes diagnosis, found to increase diabetes risk.
Read More »Real-World Benefits for SGLT-2 Inhibitors
Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.
Read More »Study Finds Moderate Increase in Physical Activity Reduces Glucose, A1c
Benefits of exercise shown to depend on duration, not exercise type
Read More »Omega-6 Fatty Acid Reduces Risk of Type 2 Diabetes
Study finds linoleic acid has long-term benefits in diabetes prevention, arachidonic acid not harmful.
Read More »Are Statins Related to Diabetes Progression?
Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.
Read More »Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy In Youth With Type 1 and 2 Diabetes
SEARCH For Diabetes In Youth Study finds more at risk of developing diabetic peripheral neuropathy than previously thought.
Read More »Calcium Score Predicts Future Heart Attack and Stroke Risk
Coronary artery calcium (CAC) scores better at predicting risk of cardiovascular disease (CVD) event in patients with type 2 than traditional scores.
Read More »